Medtronic (MDT) Tops Q3 EPS by 14c

Medtronic (NYSE: MDT) reported Q3 EPS of $1.29, $0.14 better than the analyst estimate of $1.15. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.78 billion.

Guidance:

Given the uncertainty on near-term financial results caused by the COVID-19 pandemic, the company is not providing formal annual or quarterly financial guidance at this time.

For earnings history and earnings-related data on Medtronic (MDT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating